Abstract:Breast cancer, which is the second leading cause of cancer-associated mortality in women worldwide, develops from breast tissue. Chemotherapy is the most commonly used therapy to treat breast cancer. However, a number of natural plant-derived products have been suggested as alternative therapies to treat different types of cancer, such as breast cancer. The aim of the present study was to determine the anti-tumor effects of ursolic acid and its effect on apoptosis and inflammation in breast cancer cells. The anti-cancer effects of ursolic acid were evaluated in vitro using flow cytometry, western blotting and reverse transcription-quantitative polymerase chain reaction. The results suggest that ursolic acid inhibits the viability of breast cancer cells by inducing autophagy and apoptosis without inducing cell death. Cellular migration assays demonstrated that ursolic acid was able to suppress the invasive ability of breast cancer cells (P<0.05). In addition, the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathway was downregulated following ursolic acid administration (P<0.05), leading to an upregulation of glycogen synthase kinase activity (P<0.05) and downregulation of B-cell lymphoma 2 (P<0.05), subsequently causing autophagy and apoptosis via cyclin-D1 inhibition and caspase-3 stimulation (P<0.05). Furthermore, the inflammatory response of breast cancer cells was assessed by measuring levels of nuclear factor (NF)-κB. Ursolic acid was found to downregulate NF-κB in breast cancer cells, thus inhibiting inflammation and preventing the progression of breast cancer (P<0.05). To the best of our knowledge, the present study is the first to assess the effect of ursolic acid on breast cancer cells through PI3K/AKT-regulated GSK and caspase-3 accompanied by NF-κB signaling pathways. The results of the present study regarding the potential underlying molecular mechanisms of ursolic acid may be used to develop novel therapeutic strategies for breast cancer treatment.

The expressions of COX-2,Bax and Bcl-2 in the tissues of breast cancer and intervention effect of ursolic acid

Ursolic Acid Inhibits Epithelial-Mesenchymal Transition through the Axl/NF- κ B Pathway in Gastric Cancer Cells.

The Analysis of the Anti-Tumor Mechanism of Ursolic Acid Using Connectively Map Approach in Breast Cancer Cells Line MCF-7

Expression of COX-2 in Primary Ovarian Carcinoma and the Effects of Celecoxib on the Cell Proliferation of the Human Ovarian Carcinoma Cell Line A2780

Ursolic Acid Inhibits Proliferation and Induces Apoptosis of Cancer Cells in Vitro and in Vivo

Ursolic Acid Inhibitting COX-2 Expression in Human Gastric Cancer Cell Line SGC7901

Ursolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro.

Ursolic Acid Induces Human Hepatoma Cell Line Smmc-7721 Apoptosis Via P53-Dependent Pathway

Ursolic Acid Simultaneously Targets Multiple Signaling Pathways To Suppress Proliferation And Induce Apoptosis In Colon Cancer Cells

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification

Effect of Ulinastatin and Taxotere on Proliferation,Invasion and Apoptosis of Primary Human Breast Cancer Cells and Relevant Mechanism

Ursolic Acid Overcomes Bcl-2-mediated Resistance to Apoptosis in Prostate Cancer Cells Involving Activation of JNK-induced Bcl-2 Phosphorylation and Degradation.

Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K/AKT and NF-κB signaling pathways in vitro

Mechanism of Ursolic Acid Induced Apoptosis in Human Hepatoma Cell Line SMMC-7721

Synthesis of [3Β-Acetoxy-urs-12-en-28-oyl]-1-monoglyceride and Investigation on Its Anti Tumor Effects Against BGC-823.

The Expression of Cox-2 Protein and Its Relationship to Apoptosis in Cervical Carcinoma

Ursolic acid regulates key EMT transcription factors, induces cell cycle arrest and apoptosis in MDA-MB-231 and MCF-7 breast cancer cells, an in-vitro and in silico studies

MP-15.05: Phosphorylation of Bcl-2 and Activation of Caspase-3 Via the C-Jun N-Terminal Kinase Pathway in Ursolic Acid-Induced DU145 Cells Apoptosis

The Expression of COX-2 and VEGF in Breast Cancer and Their Clinical Significance to Prognsis

Prognostic Significance of Apoptosis Related Gene Family Bcl-2 in Human Breast Cancer

Downregulation of Survivin and Activation of Caspase-3 Through the Pi3k/Akt Pathway in Ursolic Acid-Induced Hepg2 Cell Apoptosis